日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I Study of (131)I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

(131)I-间碘苄胍联合Dinutuximab±Vorinostat治疗复发或难治性神经母细胞瘤患者的I期研究:神经母细胞瘤治疗新方法试验

Cash Thomas, Marachelian Araz, DuBois Steven G, Chi Yueh-Yun, Baregamyan Anahit, Groshen Susan G, Jonus Hunter C, Shamirian Anasheh, Crowley Mary, Goodarzian Fariba, Acharya Patricia T, Pawel Bruce, Erbe Amy K, Shahi Ankita, Zaborek Jen, Kennedy Eleanor, Asgharzadeh Shahab, Villablanca Judith G, Pinto Navin, Weiss Brian D, Mosse Yael P, Desai Ami V, Macy Margaret E, Granger Meaghan, Vo Kieuhoa T, Sondel Paul M, Matthay Katherine K, Park Julie R, Goldsmith Kelly C

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.

蛋白质基因组表面组学研究发现 DLK1 是神经母细胞瘤的免疫治疗靶点

Hamilton Amber K, Radaoui Alexander B, Tsang Matthew, Martinez Daniel, Conkrite Karina L, Patel Khushbu, Sidoli Simone, Delaidelli Alberto, Modi Apexa, Rokita Jo Lynne, Lane Maria V, Hartnett Nicholas, Lopez Raphael D, Zhang Bo, Zhong Chuwei, Ennis Brian, Miller Daniel P, Brown Miguel A, Rathi Komal S, Raman Pichai, Pogoriler Jennifer, Bhatti Tricia, Pawel Bruce, Glisovic-Aplenc Tina, Teicher Beverly, Erickson Stephen W, Earley Eric J, Bosse Kristopher R, Sorensen Poul H, Krytska Kateryna, Mosse Yael P, Havenith Karin E, Zammarchi Francesca, van Berkel Patrick H, Smith Malcolm A, Garcia Benjamin A, Maris John M, Diskin Sharon J

A HORMONAL INFLUENCE? Polycystic ovary syndrome and borderline personality disorder

激素影响?多囊卵巢综合征和边缘型人格障碍

Diskin, Sharon J; Eck, Thomas; Greshock, Joel; Mosse, Yael P; Naylor, Tara; Stoeckert, Christian J Jr; Weber, Barbara L; Maris, John M; Grant, Gregory R; Akabalieva, K V; Jesus Magueta, S; Almeida, M; Osório, E; Guerra, C

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium

一项针对复发或难治性神经母细胞瘤患者的随机II期试验:MIBG对比MIBG、长春新碱和伊立替康对比MIBG和伏立诺他:来自NANT联盟的报告

DuBois, Steven G; Granger, M Meaghan; Groshen, Susan; Tsao-Wei, Denice; Ji, Lingyun; Shamirian, Anasheh; Czarnecki, Scarlett; Goodarzian, Fariba; Berkovich, Rachel; Shimada, Hiroyuki; Villablanca, Judith G; Vo, Kieuhoa T; Pinto, Navin; Mosse, Yael P; Maris, John M; Shusterman, Suzanne; Cohn, Susan L; Goldsmith, Kelly C; Weiss, Brian; Yanik, Gregory A; Twist, Clare J; Irwin, Meredith S; Haas-Kogan, Daphne A; Park, Julie R; Marachelian, Araz; Matthay, Katherine K

The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

靶向B7-H3的抗体-药物偶联物m276-SL-PBD对儿童癌症临床前实体瘤模型具有强效疗效

Kendsersky, Nathan M; Lindsay, Jarrett; Kolb, E Anders; Smith, Malcolm A; Teicher, Beverly A; Erickson, Stephen W; Earley, Eric J; Mosse, Yael P; Martinez, Daniel; Pogoriler, Jennifer; Krytska, Kateryna; Patel, Khushbu; Groff, David; Tsang, Matthew; Ghilu, Samson; Wang, Yifei; Seaman, Steven; Feng, Yang; Croix, Brad St; Gorlick, Richard; Kurmasheva, Raushan; Houghton, Peter J; Maris, John M

Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake

影像引导下活检治疗复发性神经母细胞瘤:重点关注安全性、基因测序的充分性以及肿瘤细胞百分比与病灶MIBG摄取量的相关性

Samoyedny, Andrew; Srinivasan, Abhay; States, Lisa; Mosse, Yael P; Alai, Emma; Pawel, Bruce; Pogoriler, Jennifer; Shellikeri, Sphoorti; Vatsky, Seth; Acord, Michael; Escobar, Fernando; Edgar, J Christopher; Maris, John M; Cahill, Anne Marie

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

对于新诊断的高危神经母细胞瘤患者,在诱导化疗后进行清髓性白消安/美法仑巩固治疗:儿童肿瘤协作组试验 ANBL12P1

Granger, M Meaghan; Naranjo, Arlene; Bagatell, Rochelle; DuBois, Steven G; McCune, Jeannine S; Tenney, Sheena C; Weiss, Brian D; Mosse, Yael P; Asgharzadeh, Shahab; Grupp, Stephen A; Hogarty, Michael D; Gastier-Foster, Julie M; Mills, Denise; Shulkin, Barry L; Parisi, Marguerite T; London, Wendy B; Han-Chang, John; Panoff, Joseph; von Allmen, Daniel; Jarzembowski, Jason A; Park, Julie R; Yanik, Gregory A

Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)

克唑替尼联合细胞毒性化疗治疗难治性实体瘤或间变性大细胞淋巴瘤(ALCL)患儿的安全性、耐受性和药代动力学:儿童肿瘤协作组 1 期联合研究(ADVL1212)

Greengard, Emily; Mosse, Yael P; Liu, Xiaowei; Minard, Charles G; Reid, Joel M; Voss, Stephan; Wilner, Keith; Fox, Elizabeth; Balis, Frank; Blaney, Susan M; Adamson, Peter C; Weigel, Brenda J

Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report

AZD1775联合伊立替康治疗特定儿童实体瘤的临床前评估:儿科临床前试验联盟报告

Kolb, E Anders; Houghton, Peter J; Kurmasheva, Raushan T; Mosse, Yael P; Maris, John M; Erickson, Stephen W; Guo, Yuelong; Teicher, Beverly A; Smith, Malcolm A; Gorlick, Richard

Heterozygosity mapping for human dominant trait variants

人类显性性状变异的杂合性作图

Imai-Okazaki, Atsuko; Li, Yi; Horpaopan, Sukanya; Riazalhosseini, Yasser; Garshasbi, Masoud; Mosse, Yael P; Zhang, Di; Schrauwen, Isabelle; Sharma, Aarushi; Fann, Cathy S J; Leal, Suzanne M; Lathrop, Mark; Ott, Jurg